Faron Pharmaceuticals Oy (HEL:FARON)
0.5260
+0.0040 (0.77%)
At close: Mar 18, 2026
Faron Pharmaceuticals Oy Statistics
Total Valuation
HEL:FARON has a market cap or net worth of EUR 59.63 million. The enterprise value is 72.11 million.
| Market Cap | 59.63M |
| Enterprise Value | 72.11M |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 115.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +26.21% |
| Shares Change (QoQ) | +8.03% |
| Owned by Insiders (%) | 19.52% |
| Owned by Institutions (%) | 4.85% |
| Float | 85.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -3.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -85.32% |
| Return on Invested Capital (ROIC) | -297.20% |
| Return on Capital Employed (ROCE) | 1,190.78% |
| Weighted Average Cost of Capital (WACC) | 8.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -825,970 |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HEL:FARON has paid 2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.70% in the last 52 weeks. The beta is 1.09, so HEL:FARON's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -76.70% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 29.03 |
| Average Volume (20 Days) | 1,137,590 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.27M |
| Pretax Income | -27.26M |
| Net Income | -27.26M |
| EBITDA | -20.05M |
| EBIT | -20.27M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 12.32 million in cash and 24.68 million in debt, with a net cash position of -12.36 million.
| Cash & Cash Equivalents | 12.32M |
| Total Debt | 24.68M |
| Net Cash | -12.36M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -18.51M |
| Book Value Per Share | -0.16 |
| Working Capital | -3.05M |
Cash Flow
| Operating Cash Flow | -17.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEL:FARON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.21% |
| Shareholder Yield | -26.21% |
| Earnings Yield | -45.71% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |